FilingReader Intelligence
Huadong Medicine launches 2bn yuan investment fund, pays dividend
August 19, 2025 at 05:26 PM UTC•By FilingReader AI
Huadong Medicine will establish a 2 billion yuan pharmaceutical industry investment fund with three partners, contributing 980 million yuan as a limited partner.
The board also approved a 2025 interim dividend of 3.50 yuan per 10 shares, totaling 613.9 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
Announcement on the 2025 interim profit distribution planAugust 19, 2025 at 08:00 AM UTC
Announcement regarding the commencement of hedging-oriented financial derivatives transactionsAugust 19, 2025 at 08:00 AM UTC
2025 semi-annual financial reportAugust 19, 2025 at 08:00 AM UTC
2025 semi-annual reportAugust 19, 2025 at 08:00 AM UTC
SZSE:000963•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Huadong Medicine publishes news
Free account required • Unsubscribe anytime